Wordt geladen...

Combination systemic therapies with immune checkpoint inhibitors in pancreatic cancer: overcoming resistance to single-agent checkpoint blockade

Immune checkpoint inhibitors have demonstrated broad single-agent antitumor activity and a favorable safety profile that render them attractive agents to combine with other systemic anticancer therapies. Pancreatic cancer has been fairly resistant to monotherapy blockade of programmed cell death pro...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Clin Transl Med
Hoofdauteurs: Gong, Jun, Hendifar, Andrew, Tuli, Richard, Chuang, Jeremy, Cho, May, Chung, Vincent, Li, Daneng, Salgia, Ravi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer Berlin Heidelberg 2018
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6174117/
https://ncbi.nlm.nih.gov/pubmed/30294755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-018-0210-9
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!